Cargando…

Successful Treatment with Brigatinib after Alectinib-Induced Hemolytic Anemia in Patients with Metastatic Lung Adenocarcinoma—A Case Series

Alectinib is a second-generation anaplastic lymphoma kinase (ALK) inhibitor used in the treatment of advanced ALK-rearrangement positive non-small-cell lung cancer (NSCLC). Many tolerable adverse events were reported with the use of Alectinib; nevertheless, hemolytic anemia was not mentioned in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Sayed, Rola, Tehfe, Mustapha, Blais, Normand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858242/ https://www.ncbi.nlm.nih.gov/pubmed/36661690 http://dx.doi.org/10.3390/curroncol30010041

Ejemplares similares

Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma
por: Okumoto, Joe, et al.
Publicado: (2020)

ALK ‐rearranged lung adenocarcinoma resistant to alectinib with cauliflower gingival metastasis responds to brigatinib
por: Song, Lianxi, et al.
Publicado: (2022)

Alectinib and Brigatinib: New Second-Generation ALK Inhibitors for the Treatment of Non–Small Cell Lung Cancer
por: Beardslee, Tyler, et al.
Publicado: (2018)

Immunotherapy in Extensive-Stage Small Cell Lung Cancer
por: El Sayed, Rola, et al.
Publicado: (2021)

Successful treatment with lorlatinib in a patient with meningeal carcinomatosis of ALK-positive non-small cell lung cancer resistant to alectinib and brigatinib: A case report
por: Nakashima, Koki, et al.
Publicado: (2021)

Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report
por: Misawa, Kazuhito, et al.
Publicado: (2023)

Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer in China
por: Luo, Xia, et al.
Publicado: (2022)

Pembrolizumab-related autoimmune hemolytic anemia in a patient with metastatic lung adenocarcinoma: a case report
por: Baek, Dong Won, et al.
Publicado: (2021)

Arterial thrombosis and coronavirus disease 2019 in a patient with cancer
por: Nassabein, Rami, et al.
Publicado: (2020)

Alectinib for Miliary Lung Metastasis in ALK-Positive Lung Adenocarcinoma
por: Satoh, Hironori, et al.
Publicado: (2021)

Brigatinib for non-small cell lung cancer
Publicado: (2020)

Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer with or without Central Nervous System Metastasis: A Systematic Review and Network Meta-Analysis
por: Ando, Koichi, et al.
Publicado: (2020)

Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung
por: Imanishi, Naoko, et al.
Publicado: (2018)

Alectinib-Induced Erythema Multiforme and Successful Rechallenge with Alectinib in a Patient with Anaplastic Lymphoma Kinase-Rearranged Lung Cancer
por: Kimura, Tatsuo, et al.
Publicado: (2016)

Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach
por: Carcereny, Enric, et al.
Publicado: (2021)

Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy
por: Ali, Robert, et al.
Publicado: (2019)

A Rare Association of Autoimmune Hemolytic Anemia with Gastric Adenocarcinoma
por: Agrawal, Kavita, et al.
Publicado: (2017)

Successful alectinib treatment after crizotinib‐induced interstitial lung disease
por: Fujiuchi, Satoru, et al.
Publicado: (2016)

Successful treatment with crizotinib after alectinib-induced interstitial lung disease
por: Zhu, Ning, et al.
Publicado: (2021)

Hemolytic anemia in COVID-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Improvement of EGFR Testing over the Last Decade and Impact of Delaying TKI Initiation
por: Blanc-Durand, Félix, et al.
Publicado: (2021)

Hemolytic Anemia of Malignancy: A Case Study Involving Signet Ring Cell Metastatic Breast Cancer with Severe Microangiopathic Hemolytic Anemia
por: Lee, Eric H., et al.
Publicado: (2019)

COVID-19 Impact on Diagnosis and Staging of Colorectal Cancer: A Single Tertiary Canadian Oncology Center Experience
por: Castonguay, Mathias, et al.
Publicado: (2022)

The role of brigatinib in crizotinib-resistant non-small cell lung cancer
por: Mezquita, Laura, et al.
Publicado: (2018)

An Unusual Presentation of Metastatic Breast Carcinoma as Cold Autoimmune Hemolytic Anemia
por: Chellappan, Anand, et al.
Publicado: (2015)

Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature
por: Motta, Irene, et al.
Publicado: (2021)

Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on Brigatinib
por: Rijavec, Erika, et al.
Publicado: (2022)

Alectinib treatment response in lung adenocarcinoma patient with novel EML4‐ALK variant
por: Song, Peng, et al.
Publicado: (2018)

Investigation into the Formation of Impurities during the Optimization of Brigatinib
por: Guo, Aofeng, et al.
Publicado: (2020)

Effect of severe renal impairment on the pharmacokinetics of brigatinib
por: Gupta, Neeraj, et al.
Publicado: (2021)

Brigatinib pharmacokinetics in patients with chronic hepatic impairment
por: Hanley, Michael J., et al.
Publicado: (2023)

Pulmonary hypertension in hemolytic anemias
por: Wahl, Shannon, et al.
Publicado: (2010)

About Microangiopathic Hemolytic Anemia
por: Özsoylu, Şinasi
Publicado: (2015)

Thymoma with Autoimmune Hemolytic Anemia
por: Suzuki, Kensuke, et al.
Publicado: (2014)

Ibuprofen-Induced Hemolytic Anemia
por: Barbaryan, Aram, et al.
Publicado: (2013)

Metformin-Induced Hemolytic Anemia
por: Kirkiz, Serap, et al.
Publicado: (2014)

Hemolytic Anemias: Autoimmune and Beyond
por: Krishnadasan, Ravi
Publicado: (2021)

Vancomycin-Induced Hemolytic Anemia
por: Siddiqui, Fakeha, et al.
Publicado: (2023)

nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial
por: Tehfe, Mustapha, et al.
Publicado: (2016)

A Case of Idiopathic Cold Agglutinin Hemolytic Anemia Successfully Treated With Steroids
por: Haider, Asim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k79ppd1sigt8c1jn2g5iiddco7